AbCellera Biologics (ABCL) Goodwill (2020 - 2026)

AbCellera Biologics has reported Goodwill for 7 years, with the latest figure at $47.8 million in Q1 2026.

• For the quarter ending Q1 2026, Goodwill changed 0.0% year-over-year to $47.8 million; the trailing twelve-month figure through Mar 2026 stood at $47.8 million (changed 0.0% YoY), and the FY2025 full-year result was $47.8 million, changed 0.01% from the prior year.
• Goodwill for Q1 2026 stood at $47.8 million, roughly flat from $47.8 million in the prior quarter.
• The five-year high for Goodwill was $47.8 million in Q1 2022, with the low at $47.8 million in Q4 2023.
• Historically, Goodwill has averaged $47.8 million across 5 years, with a median of $47.8 million in 2022.
• The largest YoY upside for Goodwill was 51.77% in 2022 against a maximum downside of 3.34% in 2022.
• AbCellera Biologics' Goodwill stood at $47.8 million in 2022, then declined by 0.01% to $47.8 million in 2023, then changed by 0.0% to $47.8 million in 2024, then advanced by 0.01% to $47.8 million in 2025, then changed by 0.0% to $47.8 million in 2026.
• The last three Goodwill figures came in at $47.8 million (Q1 2026), $47.8 million (Q4 2025), and $47.8 million (Q3 2025), per Business Quant data.